Biologic Drugs With Mechanism of Action: Interleukin-23 Antagonists
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Interleukin-23 Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | ⤷ Subscribe | ⤷ Subscribe |
Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 761044 | 2016-09-23 | ⤷ Subscribe | ⤷ Subscribe |
Janssen Biotech, Inc. | TREMFYA | guselkumab | Injection | 761061 | 2017-07-13 | ⤷ Subscribe | ⤷ Subscribe |
Sun Pharma Global Fze | ILUMYA | tildrakizumab-asmn | Injection | 761067 | 2018-03-20 | ⤷ Subscribe | ⤷ Subscribe |
Sun Pharma Global Fze | ILUMYA | tildrakizumab-asmn | Injection | 761067 | 2018-03-20 | 8,293,883 | ⤷ Subscribe |
Sun Pharma Global Fze | ILUMYA | tildrakizumab-asmn | Injection | 761067 | 2018-03-20 | 8,404,813 | ⤷ Subscribe |
Sun Pharma Global Fze | ILUMYA | tildrakizumab-asmn | Injection | 761067 | 2018-03-20 | 9,809,648 | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |